Ocugen, Inc.
Ocugen, Inc. (OCGN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · OCGN · as of Jun 9, 2026
Key Statistics
Explore Ocugen, Inc. Data
ocgn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 83.3%
The OCGN analyst consensus is Buy, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month price target is $5.00, representing +296.83% upside from the current price of $1.26.
Competitors & Peers
ocgn competitorsOCGN
ADCT
ALMS
CMPX
FULC
LCTXStock Performance
Full HistoryAbout Ocugen, Inc.
Ocugen, Inc. is a biopharmaceutical company in the clinical development phase, primarily dedicated to pioneering gene therapies aimed at treating various ophthalmic conditions leading to blindness. Th…
what is ocugen, inc. · ocgn stock overview · ocugen, inc. company profile · who is ocugen, inc. ceo · ocgn NASDAQ · ocugen, inc. headquarters · ocugen, inc. business segments
About Stock Overview & Key Data
Ocugen, Inc. (OCGN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 3, 2014. As of the latest trading session, OCGN stock price is $1.26, with a market capitalization of $426.5M. The stock has returned +16.97% over the past 12 months and -5.56% year-to-date.
According to 6 Wall Street analysts, the consensus rating for Ocugen, Inc. stock is Buy, with an average 12-month price target of $5.00. In fiscal year 2025, Ocugen, Inc. reported revenue of $4.4M and net income of -$67.8M. For detailed data — including Ocugen, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Ocugen, Inc. (OCGN) stock price is $1.26. The stock is traded on NASDAQ under the ticker symbol OCGN. The 52-week range is $0.90 – $2.73.